Open Access Article
Hani Nassser Abdelhamid
*a and
Mohamed E. Eissa
b
aDepartment of Chemistry, Faculty of Science, Assiut University, Assiut, 71515, Egypt
bChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia. E-mail: hany.abdelhamid@aun.edu.eg
First published on 18th March 2026
The influence of the expired drug chlorzoxazone (N-acetyl-para-aminophenol) on the corrosion behavior of 304 stainless steel (304SS) in 1.0 M hydrochloric acid was examined. Several electrochemical measurements were investigated, including open circuit potential (OCP), cyclic voltammetry (CV), potentiodynamic polarization (PD), electrochemical potentiokinetic reactivation (EPR), chronopotentiometry (CP), chronoamperometry (CA), linear sweep voltammetry (LSV), and electrochemical impedance spectroscopy (EIS) using Nquist and Bode plots. These methods were analyzed to evaluate the corrosion rate, passivation characteristics, and stability of protective films with different drug concentrations (50–400 ppm). Open-circuit measurements indicated that the incorporation of the drug altered the potential to more noble levels, suggesting surface protection. CV and LSV measurements revealed a significant reduction in current density with increasing drug concentration, validating the robust adsorption of the inhibitor molecules and establishing a stable passive film. PD and EPR findings indicated substantial decreases in corrosion current density (Icorr) and increases in polarization resistance (Rp), especially at 400 ppm, where the corrosion rate was the lowest among different drug loadings. Chronopotentiometry demonstrated consistent potential responses and improved passivation with the inhibitor, whilst chronoamperometry showed a significant reduction in dissolving current relative to uncoated steel. The data collectively indicate that the drug compound functions as an effective, concentration-dependent corrosion inhibitor, establishing a protective barrier that mitigates both anodic and cathodic processes, thus improving the electrochemical stability of stainless steel in acidic environments. This study opens a new avenue for reusing expired drugs as corrosion inhibitors.
Several molecules have been reported as corrosion inhibitors, including plant extracts,14,15 surfactants,16,17 polysaccharides,18 metal oxides,19–21 and microbial technology,22 e.g., Escherichia coli biofilm.23 Plant extracts were reported, including Tithonia diversifolia (Hemsl) A. grey leaf extract (TDLE),24 Melaleuca leaves,25 Ruta graveolens,26 Lavender angustifolia,27 Celastrus paniculatus,28 Nicotiana tabacum,29 and Prunus domestica.30 Green solvents such as ionic liquids were also reported.31 Organic molecules such as Schiff's base,32 bispyrazole derivative,33 or phytic acid/sodium phosphate34 can be used as corrosion inhibitors. Polymers or biopolymers inhibit corrosion, including polymers such as poly(ethylene terephthalate) (PET),35 N-vinylcaprolactam-acrylamide,36 chitosan,37 and a composite of different polymers.38 Drugs can also be used as inhibitors.39 Synthetic nanomaterials were reported as inhibitors, including a layered double hydroxide40 and bimetallic organic framework (CuNi-MOF).41 These materials exhibit low efficiency or are reported in less aggressive media such as 3.5 wt% NaCl.34,40 Waste materials can be reused for corrosion inhibition, including cattle manure,42 and expired chloroquine phosphate.43 Corrosion inhibitors, particularly heterocyclic organic compounds, are among the most effective solutions for safeguarding 304 SS in corrosive media. Their inhibitory effect results from adsorption onto the steel surface, which creates a protective barrier. The efficiency of metal–inhibitor coordination is significantly influenced by molecular features, including heteroatoms (N, O, P, S), aromatic rings, or extended carbon chains.
This study investigates the corrosion behavior of 304SS in 1.0 M HCl in the presence of expired chlorzoxazone/N-acetyl-para-aminophenol. The inhibition was evaluated using electrochemical measurements of open-circuit potential (OCP), cyclic voltammetry (CV), electrochemical potentiokinetic reactivation (EPR), potentiodynamic (PD), chronopotentiometry (CP), chronoamperometry (CA), linear sweep voltammetry (LSV), electrochemical impedance spectroscopy (EIS), and scanning electron microscopy (SEM) images. The expired drug exhibited effective corrosion inhibition. This study shows that expired drugs can be reused as corrosion inhibitors for stainless steel.
![]() | ||
| Fig. 1 (a) chemical structure for chlorzoxazone and N-acetyl-para-aminophenol, (b) cells setup, (c) solution before measurement, (d and e) after measurement for (d) without and (e) with drug. | ||
![]() | (1) |
The surface coverage (θ, eqn (2)) and corrosion inhibition efficiency (η, eqn (3)) were determined from electrochemical parameters, based on corrosion current density values obtained in the absence and presence of the drug.45
![]() | (2) |
![]() | (3) |
Electrochemical impedance spectroscopy (EIS) was measured using Nquist and Bode plots with a bipotentiostat CS350M (Corrtest®). Measurements were performed at least two times to ensure reproducibility.
O) functionalities, whereas N-acetyl-para-aminophenol contains hydroxyl (–OH) and amide (–NH–CO–) groups. These functional groups serve as active adsorption centers, donating lone pairs or π-electrons to the unoccupied d-orbitals of iron atoms on the stainless steel surface, forming a protective chemisorbed coating that impedes metal breakdown.
Fig. 1b illustrates the electrochemical cell arrangement, comprising stainless steel as the working electrode, Ag/AgCl as the reference electrode, and platinum as the counter electrode. The solution before measurement appears transparent, highlighting the electrolyte's original state (Fig. 1c). Post-measurement, the cell without drug additives displays a pronounced green color, indicating the formation of FeCl2 and FeCl3, confirming substantial corrosion and dissolution of the stainless steel surface (Fig. 1d). Conversely, the cell containing 400 ppm of chlorzoxazone or N-acetyl-para-aminophenol maintains a transparent solution, with the stainless steel electrode visible with no dissolution (Fig. 1e). This observation verifies that drugs efficiently mitigate corrosion by adsorbing onto the metal surface, blocking active sites, and preventing chloride-ion attack. The results unequivocally indicate that including these organic inhibitors significantly enhances the corrosion resistance of stainless steel in acidic environments.
![]() | ||
| Fig. 5 (a) chronopotentiometry and (b) chronoamperometry and (c) represented enlarged and highlighted regions. | ||
![]() | ||
| Fig. 7 SEM images of (a–c) pristine 304 SS, (d–i) 304 SS after treatment with (d–f) 50 ppm and (g–i) 400 ppm. | ||
The OCP measurements provided a preliminary assessment of corrosion propensity under each condition (Fig. 2). In 1 M HCl, a significantly negative open circuit potential (−0.318 V) indicated active dissolving and the degradation of the passive layer caused by chloride ion infiltration. Conversely, Na2SO4 demonstrated a potential of +0.105 V, indicating the durability of the passive oxide layer. As drug concentration increased, the OCP transitioned to more noble values (+0.1, +0.366, and +0.65 V), indicating that the drug inhibitor efficiently adsorbed onto the metal surface and improved passivation by decreasing the active corrosion rate. The OCP results for 304 SS exhibit a distinct, consistent trend toward noble potentials (all values reported relative to Ag/AgCl) as the medium transitions from an aggressive chloride-containing acid to a sulfate or HCl medium with increasing drug concentration. The OCP in 1 M HCl is −0.318 V, indicative of active corrosion resulting from chloride-induced degradation of the passive film. Conversely, the electrode in Na2SO4 exhibits a positive OCP of +0.105 V, indicating a passive, less reactive surface in this non-chloride electrolyte. Upon adding the drug to HCl, the OCP shifts progressively in the positive direction with increasing concentration: +0.10 V at 50 ppm, +0.366 V at 200 ppm, and +0.65 V at 400 ppm. Two primary conclusions emerge from these tendencies. The substantial negative-to-positive transition between HCl and Na2SO4 validates the potent corrosive impact of chloride. The positive shifts in OCP with increasing drug concentration indicate that organic molecules are adsorbing onto the stainless-steel surface, thereby modifying the electrochemical balance towards a more passive state. In practical terms, the adsorption and film formation by the inhibitor obstruct active dissolving sites and/or compete with Cl− adsorption, rendering the metal surface thermodynamically less susceptible to oxidation; the OCP becomes more noble as inhibitor coverage increases. It is crucial to recognize that OCP serves as a steady-state indication; the constancy of these potentials throughout the measurement indicates a stable surface condition, a consistent adsorbed coating, or a stable corrosion regime. Nevertheless, OCP alone fails to assess inhibitory efficiency or kinetic characteristics. Consequently, these favorable OCP shifts should be analyzed with other electrochemical measurements.
CV analysis was used to investigate the redox behavior and passivation properties of the stainless steel surface (Fig. 3). In HCl, CV demonstrated significant anodic dissolution and hysteresis loops characteristic of localized pitting corrosion. In Na2SO4, the CV voltammograms exhibited a more uniform current response, indicating passive behavior. Incorporating the drug markedly decreases both anodic and cathodic current densities and decreases hysteresis, validating its efficacy in inhibiting corrosion and averting pit formation. Fig. 3 presents the CV curves depicting the electrochemical behavior of 304 stainless steel in 1 M HCl, 1 M Na2SO4, and 1 M HCl with varying concentrations of the drug inhibitor (50, 200, and 400 ppm).
The current density (I, A cm−2) versus potential (E, V) profiles exhibit distinct trends that depend on the medium and inhibitor concentration, providing insights into corrosion and passivation mechanisms (Fig. 3). The stainless steel in HCl shows the highest current density, indicating active dissolution and severe corrosion from chloride-ion attack, which degrades the protective oxide layer and facilitates anodic metal dissolution (Fig. 3). The curve's shape, characterized by steep current rises at high potentials, validates passivity breakdown and localized corrosion initiation, including pitting. Conversely, the Na2SO4 medium has a significantly reduced current response, indicating a solid passive coating and less corrosion activity. Sulfate ions are less aggressive than chloride ions, facilitating the formation of a more protective oxide layer on the steel surface. Introducing the drug inhibitor to the HCl solution significantly decreases current density at all concentrations (50–400 ppm). This decrease indicates the adsorption of drug molecules onto the stainless steel surface, creating a protective barrier that hinders charge transfer and inhibits metal dissolution. The gradual decline in current density with increasing inhibitor concentration indicates a dose-dependent inhibitory effect, with 400 ppm providing the most effective corrosion mitigation, resulting in a nearly horizontal CV curve with negligible current fluctuations over the potential range. The CV results substantiate that the medication is an efficacious corrosion inhibitor for stainless steel under acidic conditions. Inhibitory efficiency increases with concentration due to the formation of a dense, adherent film of drug molecules that stabilizes the passive layer and blocks both anodic and cathodic reactions. This trend aligns with the OCP findings, indicating that the potential shifted toward more noble values in the presence of the inhibitor, thereby reinforcing the improved corrosion resistance observed with drug inclusion (Fig. 3).
Fig. 4 illustrates the PD and EPR measurements of 304SS in several corrosive environments: 1 M HCl, Na2SO4, and HCl with differing concentrations (50, 200, and 400 ppm) of the examined medication. These measurements elucidate corrosion kinetics, passivation behavior, and the drug's inhibitory efficiency. The PD curves demonstrate that stainless steel in HCl exhibits a high dissolution region, characterized by a corrosion potential (E0) of approximately −0.23 V and a substantial corrosion current density (I0 = 0.16 A cm−2), indicating significant metal degradation (Fig. 4a). The corrosion rate attains 1883 mm a−1, indicating considerable deterioration in the acidic environment. In Na2SO4, the corrosion potential increases to −0.017 V, and the corrosion current significantly decreases to 4.3 × 10−6 A cm−2, leading to a substantially reduced corrosion rate of 0.05 mm a−1. These values indicate a stable passive film and reduced corrosion in a neutral environment, i.e., a Na2SO4 electrolyte. Upon introducing the drug into the HCl solution, the E0 values shifted to more positive values, and a decrease in I0 was observed, indicating an inhibitory effect. At 50 ppm, the corrosion potential increases to 0.29 V, with I0 around 4.5 µA cm−2 and a decreased corrosion rate of approximately 0.05 mm a−1. Raising the concentration to 200 ppm further reduces the current density (2.8 µA cm−2) and corrosion rate (0.033 mm a−1), revealing high surface protection. The highest inhibition was observed at a high drug concentration (400 ppm), where the corrosion current decreased to 1.08 µA cm−2, and the corrosion rate declined to 0.013 mm a−1, indicating efficient adsorption of the drug molecules on the steel surface, resulting in a durable protective barrier. The EPR curves further validate this pattern (Fig. 4b). The charge linked to reactivation decreases with increasing drug concentration, from 0.009 C cm−2 in HCl to 0.0004 C cm−2 at 400 ppm, indicating reduced reactivation of the chromium-depleted zone and enhanced passivity. The polarization resistance (Rp) values increase significantly, from approximately 30 Ω cm2 in HCl to around 64
000 Ω cm2 at 400 ppm, indicating improved corrosion resistance. The PD and EPR analyses combined suggest that the examined medication functions as an effective mixed-type inhibitor, decreasing both anodic dissolution. The inhibitory efficacy increases with drug concentration, primarily due to the adsorption of active functional groups (such as hydroxyl and amide) onto the steel surface, which obstructs aggressive chloride ion attack and fortifies the passive layer.
Fig. 5 enhances the PD/EPR findings by illustrating the system's behavior under time-resolved settings. In the chronopotentiometry (CP), the recorded steady potentials transition from highly active to progressively noble levels as the environment alters: HCl: −0.25 V, Na2SO4: +1.30 V, and HCl combined with the medication at concentrations of 50, 200, and 400 ppm yield +1.47, +1.62, and +2.12 V, respectively (Fig. 5a). The high negative potential in unadulterated HCl indicates a surface undergoing active corrosion, with the passive coating compromised and dissolution prevailing. Conversely, potential in a noncorrosive environment (i.e., Na2SO4), particularly at high inhibitor concentrations, suggests the development or reinforcement of a passive/adsorbed protective layer. The consistent positive correlation with concentration indicates a distinct, dose-dependent enhancement in surface thermodynamic stability induced by the inhibitor. Fig. 5b (chronoamperometry, CA) offers kinetic validation. The current exhibits significant fluctuations in HCl, indicating continuous metal dissolution, film degradation, and potential localized phenomena (pitting) that result in temporary surges in anodic current. Conversely, the systems containing Na2SO4 and the administered drug demonstrate steady currents, with values indicative of the overall electrochemical activity: Na2SO4 of +1.27 µA cm−2, HCl + 50 ppm ≈ +1.92 µA cm−2, HCl + 200 ppm ≈ +0.57 µA cm−2, and HCl + 400 ppm ≈ −0.31 µA cm−2. The high variations in current for HCl indicate unregulated anodic dissolution. At a low drug inhibitor concentration (50 ppm), the current remains positive and exceeds that in Na2SO4, indicating incomplete surface covering and persistent anodic processes. Raising the concentration to 200 ppm significantly reduces the anodic current, thereby lowering dissolution rates and enhancing film coverage. At 400 ppm, the minor negative steady current indicates that cathodic processes marginally prevail, suggesting a net cathodic current, consistent with a well-formed protective layer inhibiting metal oxidation. The potentiostatic and amperometric time traces collectively demonstrate consistent and complementary behavior: the inhibitor functions in a concentration-dependent manner to (i) shift the metal to more noble potentials (stabilizing the surface) and (ii) decrease and ultimately reverse the net current, indicating significant suppression of anodic dissolution. The attenuation of current fluctuations at high drug concentrations suggests that the coating is both protective and mechanically and electrochemically stable under the specified conditions. These chrono-results therefore validate the PD/EPR findings that the medication offers high corrosion inhibition at adequate concentrations.
Fig. 6 presents LSV curves for 304 stainless steel in HCl, Na2SO4, and HCl containing different concentrations of the drug inhibitor (50, 200, and 400 ppm). The LSV technique provides insight into the system's anodic and cathodic polarization behavior, revealing how the applied potential affects corrosion and passivation. In the blank HCl solution (black curve), the current density increases sharply with potential, reflecting active dissolution of the stainless steel surface due to aggressive chloride attack, leading to a high corrosion rate. This behavior indicates the absence of a stable passive film and continuous breakdown of the protective oxide layer. In contrast, the Na2SO4 environment shows a significantly lower current response over the potential range, suggesting that sulfate ions are more aggressive than chloride ions and can even help stabilize the passive oxide layer on stainless steel. Upon introducing the drug inhibitor, notable suppression in current density is observed, particularly at higher inhibitor concentrations. At 50 ppm, the current is slightly lower than that on bare steel in HCl, indicating partial adsorption of inhibitor molecules on the metal surface. The reduction is higher at 200 ppm, suggesting that the drug molecules effectively inhibit and partially block active sites. At 400 ppm, the current density is low and nearly constant over the potential range, demonstrating strong passivation and a highly protective film that effectively suppresses corrosion. The progressive reduction in current with increasing inhibitor concentration clearly reflects the drug's dose-dependent corrosion-inhibition behavior. The inhibitor likely adsorbs to the steel surface via heteroatoms (O, N) and π-electron interactions, forming a compact barrier that limits charge transfer. Thus, the LSV data confirm that the drug significantly enhances the corrosion resistance of 304 stainless steel in acidic chloride environments, with the best inhibition efficiency observed at 400 ppm. Table 1 shows coverage and inhibition corrosion of > 0.99% and >99.9%, respectively.
| Tafel fitting | Tafel (LEV) | Integration | Rp fitting | Inhibition efficiency (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| βa (mV) | βc (mV) | I0 (A cm−2) | E0 (V) | Corrosion rate (mm a−1) | Residual | βa (mV) | βc (mV) | I0 (A cm−2) | E0 (V) | Corrosion rate (mm a−1) | Residual | Charge (Coul per cm2) | Rp (Ω cm2) | I0 (µA cm−2) | E0 (V) | Corrosion rate (mm a−1) | ||
| HCl | 20 940 |
27 631 |
0.16 | −0.23 | 1883 | 0.0015 | −620 | 209 | 0.0001 | −0.24 | 13.1 | 0.009 | 0.21144 | 30 | 80 | −0.234 | 10.1 | 0 |
| Na2SO4 | 437 | 275 | 0.0000043 | −0.017 | 0.05 | 1.7 × 10−7 | 445 | 285 | 0.0000045 | −0.02 | 0.053 | 8.7 × 10−11 | −0.0004 | 16 859 |
1.54 | −0.016 | 0.018 | 99.9 |
| 50 ppm drug | 764 | 417 | 0.0000045 | 0.288 | 0.053 | 2.82 × 10−7 | −22170 | 8653 | 0.0000049 | 0.29 | 0.058 | 1.89 × 10−8 | −0.0003 | 25 425 |
1.02 | 0.289 | 0.012 | 99.9 |
| 200 ppm | 966 | 598 | 0.00000282 | 0.14 | 0.033 | 1.26 × 10−13 | 22 170 |
8653 | 0.00000002 | 0.138 | 3.4 × 10−5 | 7.8 × 10−9 | −0.00005 | 56 743 |
45 | 0.14 | 0.0054 | 99.9 |
| 400 ppm | 2915 | 177 | 0.00000108 | −0.065 | 0.013 | 1.88 × 10−7 | 2072 | 181 | 0.00000093 | −0.065 | 0.0108 | 1.89 × 10−10 | −0.0004 | 64 168 |
40.5 | 0.064 | 0.0047 | 99.9 |
![]() | ||
| Fig. 9 Mechanism of corrosion inhibition on 304 stainless steel by adsorption of expired drug molecules. | ||
Fig. 7 displays SEM micrographs of 304 SS surfaces under various conditions. Fig. 7a and b illustrate the unaltered 304 SS surface, which shows a heterogeneous morphology with many pores and surface imperfections measuring approximately 0.1–2.6 µm. These characteristics suggest surface imperfections that may serve as preferred sites for the initiation of localized corrosion in chloride-laden environments. After administering the expired drug inhibitor at a dose of 50 ppm (Fig. 7d–f), a significant decrease in both pore density and pore size is seen. The maximal pore size decreases to approximately 1.05 µm, indicating partial surface coverage by the inhibitor molecules and the initiation of protective film formation. The adsorbed layer effectively masks surface imperfections and prevents direct electrolyte contact with the steel substrate. At a high inhibitor concentration of 400 ppm (Fig. 7g–i), the surface morphology exhibits a notable increase in smoothness, accompanied by a further decrease in pore size to roughly 0.75 µm. Furthermore, the surface is progressively covered by a uniform white layer of adsorbed drug molecules. The layer's thickness and homogeneity increase with increasing inhibitor concentration, indicating improved adsorption and superior surface passivation. The SEM images reveal that a high inhibitor concentration improves surface coverage, reduces surface porosity, and strengthens the protective barrier against chloride-induced corrosion. The morphological alterations align with the electrochemical findings, indicating enhanced corrosion inhibition efficacy at elevated medication doses.
Fig. 8 illustrates the EIS results for 304 stainless steel in the presence of varying amounts of the expired drug inhibitor. Fig. 8a displays the Nyquist plots, which show that all spectra exhibit a single semicircle, indicative of charge-transfer-controlled corrosion at the metal/solution interface. The semicircle diameter steadily increases with drug loading, indicating a substantial increase in charge-transfer resistance (Rct). This behavior suggests improved surface protection resulting from the adsorption of inhibitor molecules, which obstructs electron transport between the steel surface and the corrosive environment. Fig. 8b illustrates the associated Bode charts. The impedance modulus |Z| at low frequencies rises with inhibitor concentration, further substantiating enhanced corrosion resistance. Furthermore, the phase angle widens and shifts to higher values as drug loading increases, indicating the formation of a more capacitive, uniform protective film on the 304 SS surface. The high phase angle signifies less surface heterogeneity and improved stability of the passive layer. The expansion of the Nyquist semicircle and the enhanced Bode characteristics at high inhibitor concentration indicate that the expired medication effectively mitigates corrosion by forming an adsorbed barrier layer that improves charge transfer resistance and surface passivation. The EIS results align well with the polarization and surface morphology investigations.
Pharmaceutical compounds have been widely investigated as corrosion inhibitors, with most reported drugs achieving inhibition efficiencies (IE%) above 90% due to their molecular structures containing π-bonds, aromatic rings, and heteroatom-based functional groups (–NH2, –OH, –CN, –Cl) that enhance electron donation and adsorption onto metal surfaces (Table 2).46–48 For example, expired doxofylline (DF) exhibited 72.84% IE at 200 ppm for soft steel in 1 M HCl, which increased to 88.48% upon addition of 50 ppm KI; surface roughness decreased from 606 nm to 294 nm, confirming the formation of a protective film through mixed-type inhibition.49 Incorporation of dexamethasone sodium phosphate into LDH-coated NiTi alloys increased the interlayer spacing from 7.14 Å to 20.130 Å, improved corrosion resistance, and reduced drug release by 5%, demonstrating enhanced surface protection and biocompatibility.50 Expired Lircetam (LRTM) showed excellent performance for low-carbon steel in 1 M HCl, achieving 98.16% IE at 60 ppm, following Langmuir adsorption behavior and mixed-type inhibition, as confirmed by electrochemical, SEM/AFM, and theoretical (DFT/MD) analyses.51 Similarly, expired fluimucil (N-acetylcysteine) achieved an inhibition efficiency of 86.7% at 3.5 wt% NaCl and 90.2% in simulated acid rain, acting mainly as a cathodic inhibitor through Langmuir adsorption involving combined physisorption and chemisorption mechanisms (Table 2).52 (E)-2-((2-hydroxybenzylidene))hydrazine-1-carboxamide (HBHC) demonstrated 94.50% (PP) and 93.33% (EIS) inhibition efficiencies at 200 ppm, maintaining 97.64% efficiency after 30 days, with theoretical calculations confirming strong adsorption via donor–acceptor interactions.53 Benzothiazolium salts (BBEI and BCEI) achieved maximum efficiencies of 98.6% and 96.9%, respectively, at 10−3 M and 303 K in 1 M HCl, forming stable monolayer films consistent with Langmuir adsorption and mixed-type inhibition behavior.54 A study investigated expired chlorzoxazone (CHZ) as a corrosion inhibitor for mild steel in 1.0 M HCl over 303–333 K using weight loss, electrochemical, surface characterization, and DFT analyses.55 The results demonstrate that CHZ acts as a mixed-type inhibitor following Langmuir adsorption behavior, predominantly through physisorption, achieving up to 88.3% inhibition efficiency at 1.0 ppm by forming a protective hydrophobic adsorbed layer on the steel surface.55 In comparison, chlorzoxazone/N-acetyl-para-aminophenol exhibited exceptionally high inhibition efficiency, exceeding 99.9% at only 200 ppm, highlighting their superior performance among reported pharmaceutical-based corrosion inhibitors (Table 2).
| Inhibits | Substrate | Medium | Corrosion efficiency (%) | Inhibitor concentration (ppm) | Surface coverage | Ref. |
|---|---|---|---|---|---|---|
| Doxofylline | Soft steel | 1 M HCl | 72.84 | 200 | 0.7284 | 49 |
| Dexamethasone sodium phosphate | Nitinol | PBS | 31% | 0.31 | 50 | |
| Lircetam | Low-carbon steel (LCS) | 1 M HCl | 98.16 | 60 | 0.9816 | 51 |
| Fluimucil | Bronze | 3.5 wt% NaCl | 90.2 | 100 | 0.902 | 52 |
| HBHC | A179 mild steel | 1 M HCl | 97.64 | 200 | 0.9764 | 53 |
| Benzothiazolium salts | Carbon steel | 1 M HCl | 98.6 | 10−3 M | 0.986 | 54 |
| Chlorzoxazone (CHZ) | Mild steel (MS) | 1 M HCl | 88.3 | 1.0 ppm | 0.883 | 55 |
| Chlorzoxazone/N-acetyl-para-aminophenol | 304 SS | 1 M HCl | >99 | 200 ppm | 0.99 | This study |
| This journal is © The Royal Society of Chemistry 2026 |